Science May 04, 2020 How cells make decisions Jan Philipp Junker creates cell lineage trees. He wants to understand the different paths that lead to a functioning organism. Perhaps one day, this knowledge will also reveal how organs are able to regenerate.
Science February 26, 2020 When new blood vessels sprout Biologist Holger Gerhardt studies how blood vessels form and grow. He is currently working with clinicians in Berlin to develop new methods for preventing and treating cardiovascular diseases and cancer.
Institute & Campus February 17, 2020 By Christina Anders All of Helmholtz benefits from HIP Enabling new applications, learning from one another, linking research fields, harnessing synergies and cumulative experience in imaging processes for all: this is what the new Helmholtz Imaging Platform (HIP), coordinated by the MDC, DKFZ and DESY, promises.
Institute & Campus December 17, 2019 By Christina Anders Patient representative visits MDC Just before Christmas, Claudia Schmidtke, patient representative of the German government, visited the MDC. In the future, she wants to focus more on research on cardiovascular diseases.
Press Release No. 56 November 29, 2019 Berlin New German-Danish research collaboration to focus on Alzheimer’s New lab in Aarhus: The Novo Nordisk Foundation funds MDC scientist Thomas Willnow to the tune of €7 million.
Science October 08, 2019 By Christina Anders Copying tricks from the animal kingdom What can we learn from prairie voles, Burmese pythons, shortfin mollies, and naked mole rats? Researchers from across the world are studying unusual laboratory animals with astonishing traits in their quest to answer important questions in the fields of biomedicine and neuroscience.
Science May 23, 2019 Touch, pain and the strange sensory world of the naked mole rat Neurophysiologist Gary Lewin researches the fundamentals of pain perception at the Max Delbrück Center, where he has made inspiring discoveries – not only with naked mole rats. Lewin’s research results could lead to new pain-relieving medications for humans.
Press Release No. 18 May 03, 2019 Berlin First “wave” of the German National Cohort is completed In late April, the Berlin-North study center at the MDC welcomed its 10,000th subject in the GNC health study. This completes the first round of baseline examinations.
Science May 03, 2019 “Our goal is personalized prevention” In May 2019 the second round of examinations in the German National Cohort (GNC) health study got underway at the MDC. Tobias Pischon, an MDC researcher and a member of the GNC board of directors, explains why additional data are so important to the success of the long-term study.
Press Release No. 14 April 16, 2019 Berlin Kick-starting the kidneys with an established antifungal drug An MDC research team has discovered surprising new properties in fluconazole, a long approved fungal drug. The substance helps to draw water from urine. The researchers found this in rodents. The fungicide could help patients with rare genetic diseases in whom the water transport of the kidneys is impaired. Nevertheless, the path to therapy is not easy.
